 |
|
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Clin Mol Hepatol. 2024;30(3):406-420. Published online 2024 Apr 11 DOI: https://doi.org/10.3350/cmh.2024.0103
|
|
Citations to this article as recorded by
 Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma
Xiping Shen, Ji Wu
Clinical and Molecular Hepatology.2025; 31(1): e17. CrossRef Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
Zhanna Zhang, Gongqiang Wu
Clinical and Molecular Hepatology.2025; 31(1): e8. CrossRef Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clinical and Molecular Hepatology.2025; 31(1): e96. CrossRef Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clinical and Molecular Hepatology.2025; 31(1): e101. CrossRef Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC
Gulizaina Hapaer, Feng Che, Qing Xu, Qian Li, Ailin Liang, Zhou Wang, Jituome Ziluo, Xin Zhang, Yi Wei, Yuan Yuan, Bin Song
Frontiers in Immunology.2025;[Epub] CrossRef Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma
Deyu Kong, Yiping Zhang, Linxin Jiang, Nana Long, Chengcheng Wang, Min Qiu
Scientific Reports.2025;[Epub] CrossRef Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clinical and Molecular Hepatology.2024; 30(4): 1016. CrossRef Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
Junjie Chen, Tienan Feng, Qi Xu, Xiaoqi Yu, Yue Han, Demin Yu, Qiming Gong, Yuan Xue, Xinxin Zhang
Journal of Medical Virology.2024;[Epub] CrossRef The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
Chun‐Ting Ho, Chia‐Chu Fu, Elise Chia‐Hui Tan, Wei‐Yu Kao, Pei‐Chang Lee, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su
Journal of Gastroenterology and Hepatology.2024; 39(10): 2077. CrossRef Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clinical and Molecular Hepatology.2024; 30(4): 698. CrossRef
|